Fluoxetine Tabs 60 mg approval solidifies the company's position in the molecule by complementing the recent approval in April 2024 for Fluoxetine 10 mg and 20 mg tablets and Fluoxetine capsules
Jubilant HollisterStier is a subsidiary of Jubilant Pharma Holding
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug
Birajeev is a seasoned Supply Chain leader with an experience of 23 years
Sun Pharma has obtained rights from MSD to develop, manufacture and commercialise Tedizolid Phosphate in India
The USFDA has issued 15 observations pursuant to the completion of audit. JHSGP will submit an action plan on the observations
his strategic collaboration with BluSim Tech marks a significant milestone in Fischer MVL's journey towards expanding its healthcare portfolio
Strategic focus on India aims to make the Swoop® portable MR brain imaging system commercially available in a vast and underserved MRI market
Strides’ approval for this product marks the 1st Indian approval from the USFDA for this complex formulation
Sevelamer Carbonate Tablets approval consolidates the company's position in the Sevelamer segment
Subscribe To Our Newsletter & Stay Updated
